研究キーワード (10件)：
Pathophysiology of arteriosclerosis
, Diagnosis and treatment of heart failure
, Pathophysiology of ischemic heart disease
, 病態の解明と治療
, および 動脈硬化症の病因
, 心不全
, 虚血性疾患(狭心症・心筋梗塞)
, 循環器内科学
, Internal Medicine in General
, Cardiovascular Medicine
競争的資金等の研究課題 (4件)：
ホスホリパーゼA2受容体の解析による心血管病の成因解明と新規治療薬の開発
Molecular biology of cardiovascular diseases
Pathophysiology and therapy of atherosclerosis
Pathohpysiology and Therapy of Ischemic Heart Disease
A Specific Inhibitor of Secretory Phospholipase A2, LY374388, Attenuates Lipopolysaccharide-induced Acute Lung Injury in Mice.
(American Thoracic Society International Conference 2007 2007)
A Role for Phospholipase A2 Receptor in Lipopolysaccharide-induced Acute Lung Injury in Mice.
(American Thoracic Society International Conference 2007 2007)
The Effects of Sustained Release of Theophylline(Uniphyl®)on the Efficacy of Tiotropium Bromide in Patients with COPD.
(American Thoracic Society International Conference 2007 2007)
Blockade of AngiotensinII type1 receptor attenuates the post-infarcted cardiac dysfunction in Angiotensin converting enzyme 2 deficient mice.
(The 71th Annual Scientific Meeting of the Japanese Circulation Society 2007)
Atorvastatin Increases Plasma sFlt-1 and Decreases VEGF and PlGF in Association with Improvement of Ventricular Function in Acute Myocardial Infarction.
(The 71th Annual Scientific Meeting of the Japanese Circulation Society 2007)
